Neuropathic pain: precise sensory profiling improves treatment and calls for back-translation
- PMID: 25168667
- DOI: 10.1016/j.pain.2014.08.021
Neuropathic pain: precise sensory profiling improves treatment and calls for back-translation
Comment on
-
The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: a randomised, double-blind, placebo-controlled phenotype-stratified study.Pain. 2014 Nov;155(11):2263-73. doi: 10.1016/j.pain.2014.08.014. Epub 2014 Aug 17. Pain. 2014. PMID: 25139589 Clinical Trial.
References
-
- Baron R, Förster M, Binder A. Subgrouping of patients with neuropathic pain according to pain-related sensory abnormalities: a first step to a stratified treatment approach. Lancet Neurol. 2012;11:999-1005.
-
- Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. PAIN®. 1988;33:87-107.
-
- Burchiel KJ. Carbamazepine inhibits spontaneous activity in experimental neuromas. Exp Neurol. 1988;102:249-253.
-
- Chapman V, Suzuki R, Chamarette HL, Rygh LJ, Dickenson AH. Effects of systemic carbamazepine and gabapentin on spinal neuronal responses in spinal nerve ligated rats. PAIN®. 1998;75:261-272.
-
- Demant DT, Lund K, Vollert J, Maier C, Segerdahl M, Finnerup NB, Jensen TS, Sindrup SH. The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: A randomised, double-blind, placebo-controlled phenotype-stratified study. PAIN®. 2014;155:2263-2273.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
